Form 4: Arteris VP & General Counsel Granted 32,385 RSUs
Insider Transaction Report
Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, was granted 32,385 restricted stock units, vesting quarterly starting April 1, 2026.
Summary
- Paul L. Alpern, VP and General Counsel of Arteris, Inc. (AIP), was granted 32,385 restricted stock units (RSUs).
- Each RSU represents a contingent right to receive one share of Arteris' common stock.
- The RSUs will vest with respect to 1/16th of the total on April 1, 2026, and in equal quarterly installments thereafter.
- Following this transaction, Mr. Alpern beneficially owns 90,035 shares of common stock directly.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting standard executive compensation practices aimed at retention and alignment of interests, without indicating significant operational changes.
Positives
- Grant of 32,385 Restricted Stock Units (RSUs) to a key executive, Paul L. Alpern, aligns management incentives with shareholder interests.
- The vesting schedule promotes long-term retention of a senior officer.
Future Outlook
The granted restricted stock units are scheduled to begin vesting on April 1, 2026, with 1/16th of the total vesting on that date and the remainder vesting in equal quarterly installments thereafter, indicating a long-term incentive structure for the executive.
Industry Context
StockSavvy.ai notes that RSU grants are a common form of executive compensation across the technology and semiconductor intellectual property (IP) industries, used to attract, retain, and incentivize key talent by aligning their interests with long-term company performance.
Related Party Transactions
- The grant of 32,385 restricted stock units to Paul L. Alpern, an officer of Arteris, Inc., constitutes a transaction with a related party as part of his compensation package.
Stakeholder Impact
- Shareholders: Potential long-term benefit from executive retention and alignment of interests, as the executive's compensation is tied to stock performance.
- Employees: May signal stability in executive leadership and a commitment to long-term incentive programs.
Next Steps
- Vesting of 1/16th of the RSUs on April 1, 2026.
- Subsequent equal quarterly vesting installments of the remaining RSUs.
Key Dates
| Date | Description |
|---|---|
| 02/18/2026 | Date of transaction for the acquisition of 32,385 RSUs. |
| 02/20/2026 | Date the Form 4 was signed by Paul Alpern. |
| 04/01/2026 | First vesting date for 1/16th of the granted RSUs, with subsequent equal quarterly installments. |
Recommendation
holdThis Form 4 filing details a routine executive compensation event (RSU grant) and does not provide new material information that would significantly alter the investment thesis for Arteris, Inc. It reinforces executive retention but is not a catalyst for a 'buy' or 'sell' recommendation.
Keywords
Arteris Inc., AIP, Form 4, Restricted Stock Units, RSUs, Executive Compensation, Paul L. Alpern, Insider Transaction, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.